Your browser doesn't support javascript.
The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice.
Rhea, Elizabeth M; Logsdon, Aric F; Hansen, Kim M; Williams, Lindsey M; Reed, May J; Baumann, Kristen K; Holden, Sarah J; Raber, Jacob; Banks, William A; Erickson, Michelle A.
  • Rhea EM; Geriatrics Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA.
  • Logsdon AF; Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
  • Hansen KM; Geriatrics Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA.
  • Williams LM; Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
  • Reed MJ; Geriatrics Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA.
  • Baumann KK; Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
  • Holden SJ; Geriatrics Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA.
  • Raber J; Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
  • Banks WA; Geriatrics Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA.
  • Erickson MA; Department of Behavioral Neurosciences, Oregon Health & Science University, Portland, OR, USA.
Nat Neurosci ; 24(3): 368-378, 2021 03.
Article in English | MEDLINE | ID: covidwho-983666
ABSTRACT
It is unclear whether severe acute respiratory syndrome coronavirus 2, which causes coronavirus disease 2019, can enter the brain. Severe acute respiratory syndrome coronavirus 2 binds to cells via the S1 subunit of its spike protein. We show that intravenously injected radioiodinated S1 (I-S1) readily crossed the blood-brain barrier in male mice, was taken up by brain regions and entered the parenchymal brain space. I-S1 was also taken up by the lung, spleen, kidney and liver. Intranasally administered I-S1 also entered the brain, although at levels roughly ten times lower than after intravenous administration. APOE genotype and sex did not affect whole-brain I-S1 uptake but had variable effects on uptake by the olfactory bulb, liver, spleen and kidney. I-S1 uptake in the hippocampus and olfactory bulb was reduced by lipopolysaccharide-induced inflammation. Mechanistic studies indicated that I-S1 crosses the blood-brain barrier by adsorptive transcytosis and that murine angiotensin-converting enzyme 2 is involved in brain and lung uptake, but not in kidney, liver or spleen uptake.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Blood-Brain Barrier / Spike Glycoprotein, Coronavirus Limits: Animals / Humans / Male Language: English Journal: Nat Neurosci Journal subject: Neurology Year: 2021 Document Type: Article Affiliation country: S41593-020-00771-8

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Blood-Brain Barrier / Spike Glycoprotein, Coronavirus Limits: Animals / Humans / Male Language: English Journal: Nat Neurosci Journal subject: Neurology Year: 2021 Document Type: Article Affiliation country: S41593-020-00771-8